- Home
- SGC vs ANGO Comparison
SGC vs ANGO Comparison
Compare SGC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGC | ANGO |
|---|---|---|
| Founded | 1920 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.7M | 400.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | SGC | ANGO |
|---|---|---|
| Price | $10.24 | $13.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $17.33 | ★ $19.33 |
| AVG Volume (30 Days) | 64.8K | ★ 465.8K |
| Earning Date | 11-03-2025 | 01-07-2026 |
| Dividend Yield | ★ 5.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $565,017,000.00 | $300,718,000.00 |
| Revenue This Year | $1.07 | $8.18 |
| Revenue Next Year | $3.03 | $5.15 |
| P/E Ratio | $27.84 | ★ N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $8.30 | $8.27 |
| 52 Week High | $17.40 | $13.99 |
Technical Indicators
Market Signals| Indicator | SGC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 62.18 |
| Support Level | $9.65 | $13.02 |
| Resistance Level | $10.39 | $13.53 |
| Average True Range (ATR) | 0.38 | 0.41 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 77.51 | 70.77 |
Price Performance
Historical ComparisonAbout SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.